Kalle Alanen - UTU Research Portal

Kalle Alanen

- Docent,
Faculty of Medicine (University of Turku)

kaalan@utu.fi

Kiinamyllynkatu 10

Turku

Publications

1 of 2

Increased Expression and Altered Cellular Localization of Fibroblast Growth Factor Receptor-Like 1 (FGFRL1) Are Associated with Prostate Cancer Progression (2022)
- Cancers
Yu Lan, Toriseva Mervi, Afshan Syeda, Cangiano Mario, Fey Vidal, Erickson Andrew, Seikkula Heikki, Alanen Kalle, Taimen Pekka, Ettala Otto, Nurmi Martti, Boström Peter J, Kallajoki Markku, Tuomela Johanna, Mirtti Tuomas, Beumer Inès J, Nees Matthias, Härkönen Pirkko
(A1 Refereed original research article in a scientific journal)
Increased expression of fibroblast growth factor 13 in prostate cancer is associated with shortened time to biochemical recurrence after radical prostatectomy (2016)
- International Journal of Cancer
Yu L, Toriseva M, Tuomala M, Seikkula H, Elo T, Tuomela J, Kallajoki M, Mirtti T, Taimen P, Bostrom PJ, Alanen K, Nurmi M, Nees M, Harkonen P
(A1 Refereed original research article in a scientific journal)
Accuracy of 18F-FDG PET/CT, Multidetector CT, and MR Imaging in the Diagnosis of Pancreatic Cysts: A Prospective Single-Center Study (2015)
- Journal of Nuclear Medicine
Kauhanen S, Rinta-Kiikka I, Kemppainen J, Gronroos J, Kajander S, Seppanen M, Alanen K, Gullichsen R, Nuutila P, Ovaska J
(A1 Refereed original research article in a scientific journal)
Androgen receptor-interacting protein HSPBAP1 facilitates growth of prostate cancer cells in androgen-deficient conditions (2015)
- International Journal of Cancer
Saeed K, Ostling P, Bjorkman M, Mirtti T, Alanen K, Vesterinen T, Sankila A, Lundin J, Lundin M, Rannikko A, Nordling S, Mpindi JP, Kohonen P, Iljin K, Kallioniemi O, Rantala JK
(A1 Refereed original research article in a scientific journal)
Prebiopsy multiparametric 3T prostate MRI in patients with elevated PSA, normal digital rectal examination, and no previous biopsy (2015)
- Journal of Magnetic Resonance Imaging
Ivan Jambor, Esa Kähkönen, Pekka Taimen, Harri Merisaari, Jani Saunavaara, Kalle Alanen, Branislav Obsitnik, Heikki Minn, Viera Lehotska, Hannu J. Aronen
(A1 Refereed original research article in a scientific journal)
Lanthanide chelate complementation and hydrolysis enhanced luminescent chelate in real-time reverse transcription polymerase chain reaction assays for KLK3 transcripts (2014)
- Analytical Biochemistry
Alinezhad S, Vaananen RM, Lehmusvuori A, Karhunen U, Soukka T, Kahkonen E, Taimen P, Alanen K, Pettersson K
(A1 Refereed original research article in a scientific journal)
Pharmacologic Suppression of JAK1/2 by JAK1/2 Inhibitor AZD1480 Potently Inhibits IL-6-Induced Experimental Prostate Cancer Metastases Formation (2014)
- Molecular Cancer Therapeutics
Gu L, Talati P, Vogiatzi P, Romero-Weaver AL, Abdulghani J, Liao Z, Leiby B, Hoang DT, Mirtti T, Alanen K, Zinda M, Huszar D, Nevalainen MT
(A1 Refereed original research article in a scientific journal)
Association of transcript levels of 10 established or candidate-biomarker gene targets with cancerous versus non-cancerous prostate tissue from radical prostatectomy specimens (2013)
- Clinical Biochemistry
Vaananen RM, Lilja H, Cronin A, Kauko L, Rissanen M, Kauko O, Kekki H, Vidback S, Nurmi M, Alanen K, Pettersson K
(A1 Refereed original research article in a scientific journal)
Nuclear Stat5a/b predicts early recurrence and prostate cancer-specific death in patients treated by radical prostatectomy (2013)
- Human Pathology
Mirtti T, Leiby BE, Abdulghani J, Aaltonen E, Pavela M, Mamtani A, Alanen K, Egevad L, Granfors T, Josefsson A, Stattin P, Bergh A, Nevalainen MT
(A1 Refereed original research article in a scientific journal)
High-throughout transriptomic and RNAi analysis identifies AIM1, ERGIC1, TMED3 and TPX2 as potential drug targets in prostate cancer (2012)
- PLoS ONE
Paula Vainio, John-Patrick Mpindi, Pekka Korhonen, Vidal Fey, Tuomas Mirtti, Kalle A Alanen, Merja Perälä, Olli Kallioniemi, Kristiina Iljin
(A1 Refereed original research article in a scientific journal)